Insight into the mechanism of action of heparin cofactor Ii
Tollefsen, D.M.
Thrombosis and Haemostasis 74(5): 1209-1214
1995
ISSN/ISBN: 0340-6245 PMID: 8607096 Document Number: 442026
Document emailed within 1 workday
Related Documents
Shiba, T.; Takeuchi, S.; Awazu, S.; Igarashi, M.; Asada, T. 1978: Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(3): 560-563Sie, P.; Boneu, B. 1987: The other heparin cofactor Presse Medicale 16(4): 149-150
Kondo, S.; Niwa, M. 1985: Antithrombin IIi and heparin cofactor Ii Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 61: 106-113
Pál, A.; Sas, G. 1990: Heparin cofactor Ii studies in thrombophilic patients Orvosi Hetilap 131(9): 461
Mackie, I.J.; Segal, H.; Burren, T.; Gallimore, M.; Walshe, K.J.; Robinson, G.; Machin, S.J. 1990: Heparin cofactor Ii levels are increased by the use of combined oral contraceptives Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 1(6): 647-651
Rossi, E.B.; Duboscq, C.L.; Kordich, L.C. 1999: Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role Medicina 59(1): 95-104
Grau, E.; Oliver, A.; Félez, J.; Barceló, P.; Fernandez, C.; Ballarin, J.A.; Fontcuberta, J.; Rutllant, M.L. 1988: Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome Thrombosis and Haemostasis 60(2): 137-140
Lopaciuk, S.; Bykowska, K.; Kopeć, M. 1996: Prevalence of heparin cofactor Ii deficiency in patients with a history of venous thrombosis Polish Journal of Pharmacology 48(1): 109-111
Scully, M.F.; Ellis, V.; Kakkar, V.V. 1986: Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation Thrombosis Research 41(4): 489-499
Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309
Hayashi, T.; Sakuragawa, N. 1992: Heparin cofactor Ii inhibits thrombin-stimulated prostacyclin production by cultured vascular smooth muscle cells Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 92: 201-206
Koike, C.; Hayakawa, Y.; Niiya, K.; Sakuragawa, N.; Sasaki, H. 1996: The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1 Thrombosis and Haemostasis 75(2): 298-302
Goldberg, G.A.; Suriadnova, B.A.; Stepanov, M.A.; Kochanko, E.P. 1972: A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin Cor et Vasa 14(2): 81-95
Neekhra, N.; Padh, H. 2004: An insight into molecular mechanism of endocytosis Indian Journal of Biochemistry and Biophysics 41(2-3): 69-80
Toulon, P.; Ledjev, I.; Ozier, Y.; Garnier, J.F.; Houssin, D. 1992: Lack of correction of acquired heparin cofactor II deficiency in patients with liver failure after successful orthotopic liver transplantation Thrombosis and Haemostasis 68(2): 230-231
Kamdar, K.P.; Shelton, M.E.; Finnerty, V. 1994: The Drosophila molybdenum cofactor gene cinnamon is homologous to three Escherichia coli cofactor proteins and to the rat protein gephyrin Genetics 137(3): 791-801
Colombo, G.; Yacoub, M.R.; Burastero, S.E.; Garattini, E.; Girlanda, S.; Saporiti, N.; Salvo, F.; Sabbadini, M.G. 2009: Multiple drug hypersensivity: insight into the underlying mechanism and correlation with autoimmune diseases European Annals of Allergy and Clinical Immunology 41(2): 50-55
Tauschel, H.D.; Bonacina, F.; Galetti, F. 1984: The percutaneous action of a heparin-allantoin-dexpanthenol combination in a specific ointment base. Thrombolytic action on the rabbit ear Arzneimittel-Forschung 34(12): 1768-1772
Akai, Y.; Shiga, S.; Tohyama, K.; Shimatsu, A.; Ichiyama, S. 2000: Effect of heparin cofactor Ii on the antithrombin IIi activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women Rinsho Byori. Japanese Journal of Clinical Pathology 48(9): 867-871
Gorelik, L.; Bar-Dagan, Y.; Mokyr, M.B. 1996: Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells Journal of Immunology 156(11): 4298-4308